Bert Steffen Rosén

Title: Bert Steffen Rosén: Innovator in Blood Coagulation Screening

Introduction

Bert Steffen Rosén is a notable inventor based in Kållered, Sweden. He has made significant contributions to the field of blood coagulation through his innovative methods and technologies. With a total of three patents to his name, Rosén's work focuses on improving the screening processes for blood coagulation disorders.

Latest Patents

Rosén's latest patents include advanced in vitro methods for screening blood coagulation disorders using metal ions. These methods involve qualitative screening and quantitative determination of the functional activity of components of the Protein C anticoagulant pathway. The process entails measuring the conversion rate of a substrate by an enzyme related to Protein C anticoagulant activity in human blood samples. This is done after partial activation of coagulation through various pathways and the addition of calcium ions. The conversion rate is then compared to that of a normal human blood sample. Additionally, the methods incorporate the use of extra metal ions to enhance activity, sensitivity, and resolution. Kits and reagents for these methods are also provided.

Career Highlights

Bert Steffen Rosén is currently associated with Instrumentation Laboratory S.p.A., where he continues to develop innovative solutions in the medical field. His expertise in blood coagulation has positioned him as a key figure in advancing diagnostic methods.

Collaborations

Rosén collaborates with Christina Maria Yvonne Hall, contributing to the development of new technologies and methodologies in their field.

Conclusion

Bert Steffen Rosén's contributions to blood coagulation screening represent a significant advancement in medical diagnostics. His innovative methods and collaborative efforts continue to enhance the understanding and treatment of coagulation disorders.